DGAP-Adhoc: Gigaset AG appoints Dr. Magnus Ekerot as new CEO and Chairman of the Executive Board
2022. július 27., szerda, 08:33
DGAP-Ad-hoc: Gigaset AG / Key word(s): Personnel Ad hoc Message Bocholt, July 27th, 2022
Gigaset AG appoints Dr. Magnus Ekerot as new CEO and Chairman of the Executive Board
Dr. Magnus Ekerot succeeds Klaus Weßing (65), until now CEO and Chairman of the Executive Board of Gigaset AG, who will leave the company in the course of 2023 at the latest to retire. Dr. Ekerot, currently Senior Vice President at Bosch Security and Safety Systems, holds an MBA in strategic management and looks back on a career of more than 25 years with internationally renowned companies. Dr. Ekerot"s career has focused on IT and technology. He has already held several CEO positions. The Supervisory Board of Gigaset AG considers Dr. Ekerot to be the ideal person to lead Gigaset successfully into the next decade.
Gigaset AG, Bocholt, is an internationally active company in the field of communications technology. The company is Europe"s market leader in DECT phones and is also a leading international player with around 900 employees and sales activities in over 50 countries. In addition to DECT phones, its business activities include Android-based smartphones, cloud-based smart home applications and business telephony solutions for SMEs and enterprise customers. The traditional company is characterized in a special way by its "Made in Germany" production. The company is headquartered in Bocholt, Germany. It also maintains a software development center in Wroclaw, Poland and numerous sales offices in Europe and Asia. Gigaset AG is listed in the Prime Standard of the German Stock Exchange and is therefore subject to the highest transparency requirements. The shares are traded on the Frankfurt Stock Exchange under the symbol GGS (ISIN: DE0005156004).
|
Language: | English |
Company: | Gigaset AG |
Frankenstr. 2 | |
46395 Bocholt | |
Germany | |
Phone: | +49 (0)89 444 456 866 |
Fax: | +49(0)89 444 456 930 |
E-mail: | [email protected] |
Internet: | www.gigaset.com |
ISIN: | DE0005156004 |
WKN: | 515600 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1406523 |
End of Announcement | DGAP News Service |
1406523 27-Jul-2022 CET/CEST
Közzétételek - archívum
-
» Laxxon Medical to Participate in the BIO CEO & Investor Conference
[2023.02.02. 20:15]
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]